Cibc World Market Inc. Buys New Holdings in Astera Labs, Inc. $ALAB

Cibc World Market Inc. purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 21,796 shares of the company’s stock, valued at approximately $10,528,000.

Several other large investors have also made changes to their positions in the business. BlackRock Inc. acquired a new position in Astera Labs during the second quarter valued at $6,609,581,000. Atreides Management LP raised its stake in shares of Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after buying an additional 1,754,593 shares during the last quarter. Amundi raised its stake in shares of Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares during the last quarter. Artisan Partners Limited Partnership acquired a new position in shares of Astera Labs in the 4th quarter valued at about $148,980,000. Finally, Goldman Sachs Group Inc. boosted its stake in shares of Astera Labs by 189.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after buying an additional 858,693 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Price Performance

Astera Labs stock opened at $277.53 on Tuesday. The stock has a market capitalization of $48.15 billion, a PE ratio of 137.39 and a beta of 3.84. The business has a 50 day simple moving average of $350.46 and a 200-day simple moving average of $246.41. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the prior year, the business posted $0.44 earnings per share. The firm’s revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Citigroup reiterated a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. Stifel Nicolaus upped their price objective on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research report on Wednesday, June 24th. Rothschild & Co Redburn started coverage on shares of Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Astera Labs in a report on Tuesday, August 18th. Finally, Royal Bank Of Canada boosted their target price on shares of Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and an average target price of $333.00.

Insider Activity

In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. The trade was a 9.62% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director directly owned 75,688 shares of the company’s stock, valued at $26,882,106.96. The trade was a 11.67% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 419,244 shares of company stock worth $163,135,169. Company insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.